9th Circ. Denies Rehearing In CTI Contract Suit
A federal appeals court won't budge on its finding that Cell Therapeutics Inc.'s settlement of a qui tam suit should not preclude CTI from seeking contractual indemnification from its reimbursement consultant,...To view the full article, register now.
Already a subscriber? Click here to view full article